Ann Plast Reconstr Surg | Volume 6, Issue 1 | Case Report | Open Access

Femoral Prosthesis Fracture after Hip Arthroplasty Revision: A Case Report and Review of Literature

Yuan Long1, Li Sen1, Li Wanxiang1, Bian Jichao1, Bao Yahui2, Zhou Xiaopeng3, Wang Li3, Liu Qingkuan4, Zhang Yuanmin4 and Wang Guodong4*

1School of Clinical Medicine, Jining Medical University, China
2The Affiliated Hospital of Weifang Medical University, China
3Jining Second People's Hospital, China
4Department of Orthopedics, The Affiliated Hospital of Jining Medical University, China

*Correspondance to: Wang Guodong 

Fulltext PDF


A Solution revision prosthesis has a multilayer microporous Porocoat coating, and the availability of multiple stem body sizes ensures that the prosthesis is adapted to each patient's anatomical structure so that there a firm attachment with the bone cortex in the middle of the femur. Therefore, the Solution prosthesis is one of the most commonly used and most effective prostheses in total hip arthroplasty worldwide. We reported a case of a 54-year-old female patient with periprosthetic femoral fractures after hip arthroplasty. The case was identified as type B2 prosthesis loosening according to the Vancouver classification, and we performed revision surgery on her using the solution prosthesis. Seven months after the surgery, the patient developed a mid-femoral prosthesis fracture for no apparent reason. We performed a second revision surgery of the hip joint and allogeneic bone plate fixation, and the patient was satisfied with the treatment. For patients with type B2 prosthesis loosening and prosthesis fracture, hip arthroplasty revision and an allogeneic bone plate could be used to ensure more stable support.


Case report; Type B2 prosthesis loosening; Prosthesis fracture; Allogeneic bone plate


Long Y, Sen L, Wanxiang L, Jichao B, Yahui B, Xiaopeng Z, et al. Femoral Prosthesis Fracture after Hip Arthroplasty Revision: A Case Report and Review of Literature. Ann Plast Reconstr Surg. 2022;6(1):1084..

Subscribe to Our Newsletter